HIV Focused Sexual Risk-Reduction Interventions Targeting Adolescent Boys and Young Men in Sub-Saharan Africa: A Scoping Review
AIDS and Behavior · 2023
DOI: 10.1007/s10461-023-04054-8 ↗Kurz gefasst
Scoping Review in der Zeitschrift AIDS and Behavior, 2023. Verfasst von Roselyn Kanyemba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and AIDS Research Division (HEARD), University of KwaZulu Natal, Durban, South Africa. rkmaroses@gmail.com. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, University of KwaZulu-Natal.
Abstract (Originalsprache)
Adolescent girls and young women’s exceptionalism with HIV interventions has left adolescent boys and young men (ABYM) trailing behind, thus becoming a marginalized and underserved population. The scoping review aimed to provide an overview of interventions that have targeted sexual risk behaviors in ABYM in Sub-Saharan Africa (SSA) over the previous 21 years with critical insights on ‘what works’ in preventing the sexual transmission of HIV. A scoping review guided by Arksey and O’Malley’s (in Int J Soc Res Methodol 8(1):19–32, 16) framework and the 2015 Johanna Briggs Institute’s guidelines was conducted. A search of literature published between 2000 and 2020 was reviewed and twenty nine interventions from nine Sub Saharan African countries that met the eligibility criteria were reviewed. The review provides evidence on the successes and the limitations of sexual risk behavior interventions for ABYM in SSA. There is clear and consistent evidence that interventions reduce sexual risk behaviors in adolescent boys and young men. Their efficiency seems to grow with the length and intensity of the intervention. Positive effects were generally observed in condom use and on measures of HIV knowledge, attitudes and sexual behaviors as well as uptake of HIV tests and voluntary male circumcision. This review shows that sexual-risk interventions engaging men and boys in SSA are promising and warrant further rigorous development in terms of conceptualization, design and evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Economics and AIDS Research Division (HEARD), University of KwaZulu Natal, Durban, South Africa. rkmaroses@gmail.com.
- School of Social Sciences, University of KwaZulu Natal, Durban, South Africa. rkmaroses@gmail.com.
- Health Economics and AIDS Research Division (HEARD), University of KwaZulu Natal, Durban, South Africa.
- MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Irving Medical Center, New York, USA.
Förderung
- National Research Foundation
- University of KwaZulu-Natal
Zitieren
APA
Kanyemba, R., Govender, K., Dzomba, A., Mashamba, T. P., & Mantell, J. E. (2023). HIV Focused Sexual Risk-Reduction Interventions Targeting Adolescent Boys and Young Men in Sub-Saharan Africa: A Scoping Review. AIDS and Behavior. https://doi.org/10.1007/s10461-023-04054-8
Vancouver
Kanyemba R, Govender K, Dzomba A, Mashamba TP, Mantell JE. HIV Focused Sexual Risk-Reduction Interventions Targeting Adolescent Boys and Young Men in Sub-Saharan Africa: A Scoping Review. AIDS and Behavior. 2023. doi:10.1007/s10461-023-04054-8
BibTeX
@article{Kanyemba2023,
author = {Kanyemba, Roselyn and Govender, Kaymarlin and Dzomba, Armstrong and Mashamba, Tivani P and Mantell, Joanne E},
title = {HIV Focused Sexual Risk-Reduction Interventions Targeting Adolescent Boys and Young Men in Sub-Saharan Africa: A Scoping Review},
journal = {AIDS and Behavior},
year = {2023},
doi = {10.1007/s10461-023-04054-8}
}
EUVIMED